How to buy Elafibranor through formal channels

Elafibranor (Elafibranor) is a drug studied for the treatment of liver diseases such as non-alcoholic steatohepatitis (NASH) and primary biliary cholangitis (PBC). It is currently in different stages of clinical research and approval in many countries around the world. Since the drug has not yet been officially launched in mainland China, patients who need the drug must obtain it through other legal and compliant channels. The following are4 common formal ways to purchase medicines for patients’ reference:

First, purchase through regular overseas pharmacies or cross-border medical institutions. Many countries have allowed irafibratenol to enter the clinical or licensed drug stage. For example, in some European countries and the United States, some pharmacies or cross-border medical platforms can provide drug purchase services. Patients can place orders through legally qualified overseas pharmacies or domestically licensed cross-border medical platforms, and be sure to provide prescriptions, medical records and identity information issued by doctors to ensure safety and compliance.

Second, obtain drugs by participating in the hospital's "multidisciplinary consultation" or "clinical trial" project. Some tertiary hospitals or specialized liver disease centers may participate in international or local clinical research projects related to Elafibranor. Patients who meet the inclusion criteria can participate in trial medicines for free or at low cost. Patients can proactively consult their attending doctors or relevant research institutions to find out whether there are any projects recruiting subjects.

Third, use the channels for overseas new drugs that are urgently needed for clinical use. The National Medical Products Administration of China (NMPA) has opened a "franchised introduction" or "clinically urgently needed drug list" channel for some overseas drugs that have not yet been marketed but are urgently needed for clinical use. If Elafibranor is included in the catalog of such drugs in the future, patients can apply from designated hospitals and use the drug legally after approval.

Fourth, entrust domestic qualified drug purchasing service providers. There are currently some legally registered third-party service providers on the market that can assist patients in contacting formal overseas channels to purchase drugs. However, you need to pay special attention to check their legal qualifications, and do not use personal purchasing platforms from unknown sources to prevent you from buying fake medicines or unapproved products. During this process, it is recommended to keep all drug purchase, transportation, prescription and other materials for supervision and medical treatment needs.

In short, if patients need to use elafibratenol, it is recommended to choose legal and compliant drug purchase methods under the guidance of the attending doctor, and ensure drug safety and traceability.

Reference materials:https://www.drugs.com/